Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.